CAMX:STO
Camurus AB
SEKÂ 639.50
arrow_downward
-0.23%(-1.50) 1D
Oct 12, 5:29:49 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMX...
Open
SEKÂ 645.00
High
SEKÂ 653.50
Low
SEKÂ 630.50
Mkt. cap
38.82B
Avg. vol.
86.51K
Volume
105.24K
52-wk high
SEKÂ 710.00
52-wk low
SEKÂ 430.80
Shares outstanding
60.56M
No. of employees
316
Open
SEKÂ 645.00
High
SEKÂ 653.50
Low
SEKÂ 630.50
Mkt. cap
38.82B
Avg. vol.
86.51K
Volume
105.24K
52-wk high
SEKÂ 710.00
52-wk low
SEKÂ 430.80
Shares outstanding
60.56M
No. of employees
316
News stories
From web sources and news partners
å·´å£«çš„å ±
·
25 minutes ago
SSA Commissioner Headlines Columbus Day at the NYSE: NYSE Content Update
Foreign Policy Journal
·
11 minutes ago
SoundHound AI (NASDAQ: SOUN) Slides 46% In 2026 As Cash Burn Outpaces Revenue Growth
TradingView
·
25 minutes ago
S&P 500 expected to see 25% EPS growth as earnings kick off
Seeking Alpha
·
40 minutes ago
S&P 500 surpasses 1,000 trading days without a new 52-week low
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB
CEOFredrik Tiberg
Employees316
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitecamurus.com